Skip to content

The efficacy of automated intermittent thoracic paravertebral bolus technique for analgesia after thoracotomies: prospective, randomized, controlled, double-blind study

The efficacy of automated intermittent thoracic paravertebral bolus technique for analgesia after thoracotomies: prospective, randomized, controlled, double-blind study - The efficacy of automated intermittent thoracic paravertebral bolus technique for analgesia after thoracotomies: prospective, randomized, controlled, double-blind study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000022532
Enrollment
32
Registered
2016-05-30
Start date
2016-05-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult patients scheduled for elective unilateral thoracotomy (lung lobectomy or pulmonary segmentectomy) under combination of general anesthesia and thoracic paravertebral block

Interventions

Postoperative continuous thoracic paravertebral infusion of 0.2% levobupivacaine at 5 ml/h for 48 h Postoperative automated intermittent thoracic paravertebral bolus of 0.2% levobupivacaine 10 ml ever

Sponsors

Department of Anesthesiology, Nagasaki University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective unilateral lung lobectomy or pulmonary segmentectomy at Nagasaki University Hospital 2.American Society of Anesthesiologists Physical Status Classification I-III 3.Patients signed the informed consent form

Exclusion criteria

Exclusion criteria: 1.Age < 20 or > 80 years 2.Prior thoracotomy on ipsilateral side 3.Body mass index > 30 kg/m2 4.Body weight < 40 kg 5.Allergy to local anesthetics 6.Contraindication to non-steroidal anti-inflammatory drugs, fentanyl, iodinated contrast medium 7.Hepatic or renal failure 8.Chronic opioid use 9.Pre-existing neurological deficit 10.Infection at the site of injection 11.Bronchial asthma 12.Inability to communicate lucidly

Design outcomes

Primary

MeasureTime frame
Anesthetized dermatomes by thoracic paravertebral block 24 h after surgery

Countries

Japan

Contacts

Public ContactHiroaki Murata

Nagasaki University Graduate School of Biomedical Sciences Department of Anesthesiology

h-murata@nagasaki-u.ac.jp095-819-7370

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026